Wire Stories
-
551Tsinghua Hosts APRU Provosts� Forum 2022, Explores Futures of Higher Education
HONG KONG–(BUSINESS WIRE)–#HigherEducation–Tsinghua University hosted the Association of Pacific Rim Universities (APRU) Provosts� Forum 2022 under the theme �Futures of Higher Education�...
-
498
Synchron Announces Enrollment of First Patient in U.S. Endovascular Brain Computer Interface Study COMMAND in Patients With Severe Paralysis
– Synchron and Mount Sinai Hospital in New York Advance Industry-First FDA-Approved Clinical Trial for Brain-Computer Interface in U.S. – Paralysis is...
-
498
VMware and Wipro Expand Partnership to Power Customers� Digital Transformation
Companies extend decade-long partnership to help customers across industries realize value faster from app and cloud modernization initiatives PALO ALTO, Calif. &...
-
483
VMware and Wipro Expand Partnership to Power Customers� Digital Transformation
Companies extend decade-long partnership to help customers across industries realize value faster from app and cloud modernization initiatives PALO ALTO, Calif. &...
-
485
Synchron Announces Enrollment of First Patient in U.S. Endovascular Brain Computer Interface Study COMMAND in Patients With Severe Paralysis
– Synchron and Mount Sinai Hospital in New York Advance Industry-First FDA-Approved Clinical Trial for Brain-Computer Interface in U.S. – Paralysis is...
-
491
Synchron Announces Enrollment of First Patient in U.S. Endovascular Brain Computer Interface Study COMMAND in Patients With Severe Paralysis
– Synchron and Mount Sinai Hospital in New York Advance Industry-First FDA-Approved Clinical Trial for Brain-Computer Interface in U.S. – Paralysis is...
-
494
OliX Pharmaceuticals Identifies Effective Inhibition of Target Gene Expression and Delivery of Candidate to Brain for CNS Therapeutics
SUWON, South Korea–(BUSINESS WIRE)–#AlzheimersDisease—OliX Pharmaceuticals, Inc. (KOSDAQ: 226950), a leading developer of RNAi therapeutics, today announced that the Company identified effective inhibition...
-
551Diamond Equity Research Releases Update Note on Medigus Limited (NASDAQ: MDGS)
NEW YORK, May 04, 2022 (GLOBE NEWSWIRE) — Diamond Equity Research, a leading equity research firm with a focus on small capitalization...
-
445ARKO Reports First Quarter 2022 Results
Net Income Increases by $17.0 Million; Adjusted EBITDA Grows 18.4% in Q1 2022 Compared to Q1 2021; Fuel, Merchandise Contribution Grows Beats...
-
554
Xperi and LAPIS, a ROHM Group Company, Enter into Hybrid Bonding License Agreement
Technology transfer includes DBI� Ultra die-to-wafer hybrid bonding know-how SAN JOSE, Calif. & YOKOHAMA, Japan–(BUSINESS WIRE)–Adeia, the newly launched brand for the...
